October FDA Calendar Stocks

Seeking Alpha has reported on 6 stocks with expected catalysts during the month of October, including 3 pending FDA decisions, updated clinical trial data, and an expected FDA filing to expand the label of an existing product.

The 6 Companies and new products are:

• BioSante Pharma (NASDAQ: BPAX): LibiGel
• GTx Inc. (NASDAQ: GTXI): Toremifene
• Amgen (NASDAQ: AMGN ): Prolia
• ImmunoCellular Therapeutics (OTC: IMUC.OB): Dendritic Cell Based Cancer Antigen Vaccine
• Questcor Pharma (NASDAQ: QCOR): H.P. Acthar Gel
• Transcept Pharma (NASDAQ: TSPT) : Intermezzo- Prescription Sleep Aid

Three of the stocks (BPAX, IMUC, QCOR) do not carry the added risk of depending on an actual decision by the FDA.

Read the full article, including more information about the products to be released and stock projections, here:
http://seekingalpha.com/article/166923-october-fda-calendar-stocks-tricks-or-treats